Clinical and business development of a novel drug improvement technology

Ceridia has developed a novel drug reformulation system which can be used to improve the performance of new and existing medications. Problems such as poor drug solubility can be improved by the system, which has the capability to make injectable only drugs suitable for oral administration. The ability to enhance new and existing medicines is expected to improve clinical outcomes for patients. Funding from Commercialisation Australia will be used to support planning in preparation for clinical development and equity investment.